1438533 - Retrophin, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - RTRX (1438533)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
33 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P2-1-2-5+8
S4+0+8+4+20

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2018-02-14
RTRXRote William E.SVP, R, DS - Sale$21.50-1,03411,156-8%-$22,232
2018-02-08
RTRXReed Elizabeth ESVP, GC, Corporate SecretaryA - Grant$0.00+1,76910,827+20%+$0
2018-02-08
RTRXRote William E.SVP, R, DA - Grant$0.00+1,98512,190+19%+$0
2018-02-08
RTRXClague LauraCFOA - Grant$0.00+2,0332,033New+$0
2018-02-08
RTRXMcFarlane Neil F.COOA - Grant$0.00+2,54617,448+17%+$0
2018-02-08
RTRXAselage SteveCEOA - Grant$0.00+3,549221,105+2%+$0
2018-01-05
RTRXReed Elizabeth ESVP, GC, Corporate SecretaryS - Sale$24.04-9429,058-9%-$22,646
M
2017-12-21
RTRXAselage SteveCEOG - Gift$0.00-28,000217,556-11%-$0
2017-08-16
RTRXMcFarlane Neil F.COOS - Sale$22.50-1,37813,622-9%-$31,005
2017-06-14
RTRXAselage SteveCEOP - Purchase$17.85+5,000245,556+2%+$89,250
D
2017-05-17
RTRXKozarich John WDirA - Grant$0.00+2,50024,500+11%+$0
D
2017-05-17
RTRXLyons Gary ADirA - Grant$0.00+2,50026,500+10%+$0
D
2017-05-17
RTRXMeckler Jeffrey ADirA - Grant$0.00+2,50056,500+5%+$0
D
2017-05-17
RTRXBaynes Roy D.DirA - Grant$0.00+2,5006,500+63%+$0
D
2017-05-17
RTRXCoughlin Timothy PDirA - Grant$0.00+2,50024,500+11%+$0
D
2017-04-10
RTRXSquarer RonDirA - Grant$0.00+4,3754,375New+$0+1+2-4
D
2017-03-23
RTRXOrwin John ADirA - Grant$0.00+4,3754,375New+$0-2+3+8
D
2017-02-13
RTRXRote William E.SVP, R, DA - Grant$0.00+10,00010,000New+$0-2-1-10
D
2017-01-04
RTRXReed Elizabeth ESVP, GC, Corporate SecretaryA - Grant$0.00+10,00010,000New+$0+2-1+4
2016-11-21
RTRXAselage SteveCEOG - Gift$0.00-57,000240,556-19%-$0+1-5-13
M
2016-11-21
RTRXAselage SteveCEOS - Sale$21.12-8,200240,556-3%-$173,160+1-5-13
2016-09-01
RTRXShih AlvinEVP of Research, DevelopmentS - Sale$16.24-8,750158,334-5%-$142,059+1+32+43+31
D
2016-08-15
RTRXMcFarlane Neil F.COOA - Grant$0.00+15,00015,000New+$0-2-5+32+17
D
2016-07-19
RTRXBaynes Roy D.DirA - Grant$0.00+4,0004,000New+$0+1+2-4+7
2016-06-01
RTRXShih AlvinEVP of Research, DevelopmentS - Sale$17.75-8,750167,084-5%-$155,284-30-2+18
D
2016-05-18
RTRXLyons Gary ADirA - Grant$0.00+2,00024,000+9%+$0-1+5+6+28
D
2016-05-18
RTRXKozarich John WDirA - Grant$0.00+2,00022,000+10%+$0-1+5+6+28
D
2016-05-18
RTRXGolding Cornelius EDirA - Grant$0.00+2,00029,000+7%+$0-1+5+6+28
D
2016-05-18
RTRXCoughlin Timothy PDirA - Grant$0.00+2,00022,000+10%+$0-1+5+6+28
D
2016-05-18
RTRXMeckler Jeffrey ADirA - Grant$0.00+2,00054,000+4%+$0-1+5+6+28
2016-03-04
RTRXMeckler Jeffrey ADirP - Purchase$15.31+5,00052,000+11%+$76,565-4-5-9+4
2016-03-03
RTRXMeckler Jeffrey ADirP - Purchase$14.45+10,00047,000+27%+$144,500+2+2-1+11
2016-03-01
RTRXShih AlvinEVP of Research, DevelopmentS - Sale$14.35-8,750175,834-5%-$125,569+3+6-11+10

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top